Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $3.71 Million - $4.61 Million
-4,800 Reduced 6.15%
73,200 $64.9 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $13 Million - $16.3 Million
-17,900 Reduced 18.67%
78,000 $70.6 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $9.77 Million - $13.1 Million
16,500 Added 20.78%
95,900 $74.6 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $1.52 Million - $1.8 Million
-2,900 Reduced 3.52%
79,400 $46.3 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $14.6 Million - $20.2 Million
33,700 Added 69.34%
82,300 $44.2 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $15.9 Million - $21.2 Million
45,200 Added 1329.41%
48,600 $22.8 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $1.4 Million - $1.64 Million
-4,500 Reduced 56.96%
3,400 $1.17 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $900,340 - $1.05 Million
-2,800 Reduced 26.17%
7,900 $2.89 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $3.17 Million - $3.62 Million
10,700 New
10,700 $3.46 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $327,407 - $394,032
-2,400 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $440,485 - $545,195
-3,700 Reduced 60.66%
2,400 $333,000
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $555,984 - $688,636
-5,200 Reduced 46.02%
6,100 $802,000
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $106,790 - $116,160
-1,000 Reduced 8.13%
11,300 $1.26 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $177,264 - $206,912
1,600 Added 14.95%
12,300 $1.36 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $1.19 Million - $1.4 Million
10,700 New
10,700 $1.39 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.